1) liver concertration
肝脏药物浓度
2) liver homogenate concentration
肝脏匀浆浓度
3) Drug concentration
药物浓度
1.
AIM To establish a simple and practical method for the estimation of the inter-patient variability of cytochrome P450(CYP3A)enzyme activity and to predict drug concentration and parmacokinetics of etoposide with the variability of CYP3A in chidren patients with leukemia.
方法采用HPLC测定药物浓度,一点法计算药物消除半衰期,尿样法测定体内CYP3A酶活性。
2.
Objective: To establish a HPLC method for the determination of the drug concentration in bile after the injection of lomefloxacine.
目的:建立用HPLC方法测定注射洛美沙星后不同时间的胆汁药物浓度。
3.
It was found that SM2 was absorbed quickly and distributed widely, the concentrations in the tissues of heart, liver, lung, kidney and small intestine were all higher,facially, the drug concentration in the tissue of small intestine was highest.
5h药物浓度高达27。
4) plasma concentration
药物浓度
1.
Association between valproic acid plasma concentration and CYP2C19 gene ploymorphism;
丙戊酸药物浓度与 CYP2C19 基因多态性关系的研究
5) drug-induced liver dysfunction
药物性肝脏损害
1.
Objective To investigate whether the sort of drugs causing drug eruptions complicated with drug-induced liver dysfunction are the same as those causing drug eruptions.
结论对本组回顾性分析发现各种致敏药物引起药物性肝脏损害在排序上与所致药疹发生率有所不同 ,故在临床治疗用药以及药疹诊治方面应值得注意。
6) drug-metabolizing enzymes
肝脏药物代谢酶
1.
The levels of liver microsomal protein,cytochrome P-450(Cyt P-450)and b 5(Cyt b 5 ),liver drug-metabolizing enzymes were determined,respect.
于感染后第 3,6 ,9,11和 13周分别宰杀 12只 (感染组 8只 ,对照组 4只 )大鼠 ,测定其肝微粒体蛋白、细胞色素P 4 5 0、细胞色素b5的浓度和肝脏药物代谢酶活性。
2.
【Result】 Intraperitoneal injection of Streptococcus suis resulted in a time-dependent modulation of hepatic drug-metabolizing enzymes activities in mice.
【目的】评价猪链球菌感染对小鼠肝脏药物代谢酶活性的影响。
补充资料:肝脏药物代谢酶
分子式:
CAS号:
性质:又称混合功能氧化酶。这一酶系统的活性需要有还原物质NADPH及分子氧的存在,其中两个微粒体酶起着关键作用。第一个酶是黄素蛋白-NADPH-细胞色素P-450还原酶;另一个酶为一种血红素蛋白,又称细胞色素P-450,它是一个末端氧化酶。
CAS号:
性质:又称混合功能氧化酶。这一酶系统的活性需要有还原物质NADPH及分子氧的存在,其中两个微粒体酶起着关键作用。第一个酶是黄素蛋白-NADPH-细胞色素P-450还原酶;另一个酶为一种血红素蛋白,又称细胞色素P-450,它是一个末端氧化酶。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条